Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific AI In Drug Repurposing Market, by Component
1.4.2 Asia Pacific AI In Drug Repurposing Market, by Technology
1.4.3 Asia Pacific AI In Drug Repurposing Market, by End Use
1.4.4 Asia Pacific AI In Drug Repurposing Market, by Application
1.4.5 Asia Pacific AI In Drug Repurposing Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis
Chapter 4. Market Trends – Asia Pacific AI In Drug Repurposing Market
Chapter 5. State of Competition – Asia Pacific AI In Drug Repurposing Market
Chapter 6. Value Chain Analysis of AI In Drug Repurposing Market
Chapter 7. Product Life Cycle – AI In Drug Repurposing Market
Chapter 8. Market Consolidation – AI In Drug Repurposing Market
Chapter 9. Key Customer Criteria – AI In Drug Repurposing Market
Chapter 10. Asia Pacific AI In Drug Repurposing Market by Component
10.1 Asia Pacific Software & Platform Market by Country
10.2 Asia Pacific Services Market by Country
Chapter 11. Asia Pacific AI In Drug Repurposing Market by Technology
11.1 Asia Pacific Machine Learning/Deep Learning Market by Country
11.2 Asia Pacific Natural Language Processing (NLP) Market by Country
11.3 Asia Pacific Knowledge Graphs & Network-Based AI Market by Country
11.4 Asia Pacific Generative AI & Large Language Models (LLMs) Market by Country
11.5 Asia Pacific Computer Vision Market by Country
Chapter 12. Asia Pacific AI In Drug Repurposing Market by End Use
12.1 Asia Pacific Pharmaceutical & BioTechnology Companies Market by Country
12.2 Asia Pacific Contract Research Organizations (CROs) Market by Country
12.3 Asia Pacific Academic & Research Institutes Market by Country
12.4 Asia Pacific Other End Use Market by Country
Chapter 13. Asia Pacific AI In Drug Repurposing Market by Application
13.1 Asia Pacific Oncology Market by Country
13.2 Asia Pacific Neurology Market by Country
13.3 Asia Pacific Infectious Diseases Market by Country
13.4 Asia Pacific Rare & Orphan Diseases Market by Country
13.5 Asia Pacific Cardiology Market by Country
13.6 Asia Pacific Other Application Market by Country
Chapter 14. Asia Pacific AI In Drug Repurposing Market by Country
14.1 China AI In Drug Repurposing Market
14.1.1 China AI In Drug Repurposing Market by Component
14.1.2 China AI In Drug Repurposing Market by Technology
14.1.3 China AI In Drug Repurposing Market by End Use
14.1.4 China AI In Drug Repurposing Market by Application
14.2 Japan AI In Drug Repurposing Market
14.2.1 Japan AI In Drug Repurposing Market by Component
14.2.2 Japan AI In Drug Repurposing Market by Technology
14.2.3 Japan AI In Drug Repurposing Market by End Use
14.2.4 Japan AI In Drug Repurposing Market by Application
14.3 India AI In Drug Repurposing Market
14.3.1 India AI In Drug Repurposing Market by Component
14.3.2 India AI In Drug Repurposing Market by Technology
14.3.3 India AI In Drug Repurposing Market by End Use
14.3.4 India AI In Drug Repurposing Market by Application
14.4 South Korea AI In Drug Repurposing Market
14.4.1 South Korea AI In Drug Repurposing Market by Component
14.4.2 South Korea AI In Drug Repurposing Market by Technology
14.4.3 South Korea AI In Drug Repurposing Market by End Use
14.4.4 South Korea AI In Drug Repurposing Market by Application
14.5 Singapore AI In Drug Repurposing Market
14.5.1 Singapore AI In Drug Repurposing Market by Component
14.5.2 Singapore AI In Drug Repurposing Market by Technology
14.5.3 Singapore AI In Drug Repurposing Market by End Use
14.5.4 Singapore AI In Drug Repurposing Market by Application
14.6 Malaysia AI In Drug Repurposing Market
14.6.1 Malaysia AI In Drug Repurposing Market by Component
14.6.2 Malaysia AI In Drug Repurposing Market by Technology
14.6.3 Malaysia AI In Drug Repurposing Market by End Use
14.6.4 Malaysia AI In Drug Repurposing Market by Application
14.7 Rest of Asia Pacific AI In Drug Repurposing Market
14.7.1 Rest of Asia Pacific AI In Drug Repurposing Market by Component
14.7.2 Rest of Asia Pacific AI In Drug Repurposing Market by Technology
14.7.3 Rest of Asia Pacific AI In Drug Repurposing Market by End Use
14.7.4 Rest of Asia Pacific AI In Drug Repurposing Market by Application
Chapter 15. Company Profiles
15.1 Ginkgo Bioworks Holdings, Inc.
15.1.1 Company Overview
15.1.2 Financial Analysis
15.1.3 Segmental and Regional Analysis
15.1.4 Research & Development Expenses
15.1.5 Recent strategies and developments:
15.1.5.1 Partnerships, Collaborations, and Agreements:
15.1.6 SWOT Analysis
15.2 IBM Corporation
15.2.1 Company Overview
15.2.2 Financial Analysis
15.2.3 Regional & Segmental Analysis
15.2.4 Research & Development Expenses
15.2.5 Recent strategies and developments:
15.2.5.1 Partnerships, Collaborations, and Agreements:
15.2.6 SWOT Analysis
15.3 Atomwise, Inc.
15.3.1 Company Overview
15.4 Cyclica, Inc.
15.4.1 Company Overview
15.5 Genesis Healthcare Co.
15.5.1 Company Overview
15.6 Verge, Inc.
15.6.1 Company Overview
15.7 Novartis AG
15.7.1 Company Overview
15.7.2 Financial Analysis
15.7.3 Segmental and Regional Analysis
15.7.4 Research & Development Expenses
15.7.5 SWOT Analysis
15.8 Schrödinger, Inc
15.8.1 Company Overview
15.8.2 Financial Analysis
15.8.3 Segmental and Regional Analysis
15.8.4 Research & Development Expenses
15.9 Recursion Pharmaceuticals, Inc.
15.9.1 Company Overview
15.9.2 Financial Analysis
15.9.3 Research & Development Expenses
15.10. The Cradle Company
15.10.1 Company Overview
Unique Offerings 